231 related articles for article (PubMed ID: 22020674)
21. [Correlation of caveolin-1 expression with clinicopathologic features and prognosis in patients with lung adenocarcinoma].
Wang Y; Liu B; Xu Y; Zhang J; Xia Q; Yu B; Zhang R; Shi S; Lu Z; Zhou X
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):251-5. PubMed ID: 24915816
[TBL] [Abstract][Full Text] [Related]
22. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
[TBL] [Abstract][Full Text] [Related]
23. Presence of micropapillary and solid patterns are associated with nodal upstaging and unfavorable prognosis among patient with cT1N0M0 lung adenocarcinoma: a large-scale analysis.
Yuan Y; Ma G; Zhang Y; Chen H
J Cancer Res Clin Oncol; 2018 Apr; 144(4):743-749. PubMed ID: 29392402
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance and adjuvant chemotherapy survival benefits of a solid or micropapillary pattern in patients with resected stage IB lung adenocarcinoma.
Qian F; Yang W; Wang R; Xu J; Wang S; Zhang Y; Jin B; Yu K; Han B
J Thorac Cardiovasc Surg; 2018 Mar; 155(3):1227-1235.e2. PubMed ID: 29223834
[TBL] [Abstract][Full Text] [Related]
25. The new IASLC-ATS-ERS lung adenocarcinoma classification: what the surgeon should know.
Eguchi T; Kadota K; Park BJ; Travis WD; Jones DR; Adusumilli PS
Semin Thorac Cardiovasc Surg; 2014; 26(3):210-22. PubMed ID: 25527015
[TBL] [Abstract][Full Text] [Related]
26. [Association between the presence of solid or micropapillary components and survival outcome in stage ⅠA lung adenocarcinoma cases: a retrospective cohort study].
Jin KQ; Shen YR; Wu YM; Dai J; Liu XG; Li JQ; Chen LS; Jiang GN
Zhonghua Wai Ke Za Zhi; 2022 Jun; 60(6):587-592. PubMed ID: 35658347
[No Abstract] [Full Text] [Related]
27. Pathologic heterogeneity of lung adenocarcinomas: A novel pathologic index predicts survival.
Lee G; Choi ER; Lee HY; Jeong JY; Ahn JH; Kim S; Bae J; Kim HK; Choi YS; Kim J; Zo J; Lee KS; Shim YM
Oncotarget; 2016 Oct; 7(43):70353-70363. PubMed ID: 27612421
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
Deng C; Zhang Y; Ma Z; Fu F; Deng L; Li Y; Chen H
J Thorac Cardiovasc Surg; 2021 Sep; 162(3):664-674.e7. PubMed ID: 32747123
[TBL] [Abstract][Full Text] [Related]
29. Non-terminal respiratory unit type lung adenocarcinoma has three distinct subtypes and is associated with poor prognosis.
Sumiyoshi S; Yoshizawa A; Sonobe M; Kobayashi M; Sato M; Fujimoto M; Tsuruyama T; Date H; Haga H
Lung Cancer; 2014 Jun; 84(3):281-8. PubMed ID: 24725383
[TBL] [Abstract][Full Text] [Related]
30. High-grade lung adenocarcinomas with micropapillary and/or solid patterns: a review.
Morales-Oyarvide V; Mino-Kenudson M
Curr Opin Pulm Med; 2014 Jul; 20(4):317-23. PubMed ID: 24852329
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Study of Surgical Treated Lung Adenocarcinoma with Ground Glass Nodule Component.
Xu Y; Zheng M; Wang N; Wang R
Med Sci Monit; 2019 Nov; 25():8492-8498. PubMed ID: 31710020
[TBL] [Abstract][Full Text] [Related]
32. Solid Predominant Histologic Subtype in Resected Stage I Lung Adenocarcinoma Is an Independent Predictor of Early, Extrathoracic, Multisite Recurrence and of Poor Postrecurrence Survival.
Ujiie H; Kadota K; Chaft JE; Buitrago D; Sima CS; Lee MC; Huang J; Travis WD; Rizk NP; Rudin CM; Jones DR; Adusumilli PS
J Clin Oncol; 2015 Sep; 33(26):2877-84. PubMed ID: 26261257
[TBL] [Abstract][Full Text] [Related]
33. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee.
Moreira AL; Ocampo PSS; Xia Y; Zhong H; Russell PA; Minami Y; Cooper WA; Yoshida A; Bubendorf L; Papotti M; Pelosi G; Lopez-Rios F; Kunitoki K; Ferrari-Light D; Sholl LM; Beasley MB; Borczuk A; Botling J; Brambilla E; Chen G; Chou TY; Chung JH; Dacic S; Jain D; Hirsch FR; Hwang D; Lantuejoul S; Lin D; Longshore JW; Motoi N; Noguchi M; Poleri C; Rekhtman N; Tsao MS; Thunnissen E; Travis WD; Yatabe Y; Roden AC; Daigneault JB; Wistuba II; Kerr KM; Pass H; Nicholson AG; Mino-Kenudson M
J Thorac Oncol; 2020 Oct; 15(10):1599-1610. PubMed ID: 32562873
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
[TBL] [Abstract][Full Text] [Related]
35. Prognostic relevance of TTF-1 expression in stage I adenocarcinoma.
Zhou C; Zhao J; Shao J; Li W
Oncotarget; 2017 Dec; 8(64):107462-107468. PubMed ID: 29296178
[TBL] [Abstract][Full Text] [Related]
36. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas.
Lee HY; Cha MJ; Lee KS; Lee HY; Kwon OJ; Choi JY; Kim HK; Choi YS; Kim J; Shim YM
J Thorac Oncol; 2016 Jul; 11(7):1064-73. PubMed ID: 27016260
[TBL] [Abstract][Full Text] [Related]
37. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
38. Negative Thyroid Transcription Factor 1 Expression Defines an Unfavorable Subgroup of Lung Adenocarcinomas.
Zhang Y; Wang R; Li Y; Pan Y; Hu H; Zhang Y; Li H; Shen L; Yu Y; Sun Y; Chen H
J Thorac Oncol; 2015 Oct; 10(10):1444-50. PubMed ID: 26200450
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of complex glandular patterns in invasive pulmonary adenocarcinomas.
Bossé Y; Gagné A; Althakfi W; Orain M; Fiset PO; Desmeules P; Joubert P
Hum Pathol; 2022 Oct; 128():56-68. PubMed ID: 35872155
[TBL] [Abstract][Full Text] [Related]
40. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
